Guillain-Barré Syndrome outbreak associated with Zika virus infection in French Polynesia: a case-control study.

PubWeight™: 10.08‹?› | Rank: Top 0.1%

🔗 View Article (PMID 26948433)

Published in Lancet on March 02, 2016


V M Cao-Lormeau1, A Blake2, S Mons3, S Lastere4, C Roche1, J Vanhomwegen5,6, T Dub2, L Baudouin3, A Teissier1, P Larre7, A L Vial8, C Decam9, V Choumet6, S K Halstead10, H J Willison10, L Musset11, J C Manuguerra5,6, P Despres12, E Fournier13, H P Mallet8, D Musso1, A Fontanet2,14,15, J Neil11, F Ghawché7

Author Affiliations

1: Unit of Emerging Infectious Diseases, Institut Louis Malardé, Papeete, Tahiti, French Polynesia.
2: Institut Pasteur, Emerging Diseases Epidemiology Unit, Paris, France.
3: Service de réanimation polyvalente, Centre Hospitalier de Polynésie française, Tahiti, French Polynesia.
4: Clinical laboratory, Centre Hospitalier de Polynésie française, Tahiti, French Polynesia.
5: Institut Pasteur, Laboratory for Urgent Responses to Biological Threats, Paris, France.
6: Unit Environment and Infectious Risks, Institut Pasteur, Paris, France.
7: Service de neurologie, Centre Hospitalier de Polynésie française, 98713 Papeete, Tahiti, Polynésie française.
8: Direction de la santé, Bureau de Veille Sanitaire, Papeete, French Polynesia.
9: Service de santé des forces armées, French Polynesia.
10: Institute of Infection, Immunity and Inflammation, College of Medical, Veterinary and Life Sciences, University of Glasgow, UK.
11: Department of Immunology, Laboratory of Immunochemistry & Autoimmunity, Pitié-Salpêtrière Hospital (AP-HP), Paris, France.
12: UMR 134 PIMIT, University of Reunion island, INSERM U1187, CNRS 9192, IRD 249, La Reunion, 97491, France.
13: Département de Neurophysiologie, Pitié-Salpêtrière Hospital (AP-HP), Paris, France.
14: Conservatoire National des Arts et Métiers, Paris, France.
15: Institut Pasteur, Centre for Global Health Research and Education, Paris, France.

Articles citing this

(truncated to the top 100)

The Brazilian Zika virus strain causes birth defects in experimental models. Nature (2016) 4.71

Zika virus in the Americas: Early epidemiological and genetic findings. Science (2016) 4.49

A Mouse Model of Zika Virus Pathogenesis. Cell Host Microbe (2016) 3.20

Zika virus: History, emergence, biology, and prospects for control. Antiviral Res (2016) 2.13

Dengue virus sero-cross-reactivity drives antibody-dependent enhancement of infection with zika virus. Nat Immunol (2016) 2.08

The 3.8 Å resolution cryo-EM structure of Zika virus. Science (2016) 2.07

Zika Virus: New Clinical Syndromes and Its Emergence in the Western Hemisphere. J Virol (2016) 2.03

Transmission Dynamics of Zika Virus in Island Populations: A Modelling Analysis of the 2013-14 French Polynesia Outbreak. PLoS Negl Trop Dis (2016) 1.47

Identification of small-molecule inhibitors of Zika virus infection and induced neural cell death via a drug repurposing screen. Nat Med (2016) 1.43

Assessing the global threat from Zika virus. Science (2016) 1.32

Human antibody responses after dengue virus infection are highly cross-reactive to Zika virus. Proc Natl Acad Sci U S A (2016) 1.31

Outbreak of Zika Virus Infection, Chiapas State, Mexico, 2015, and First Confirmed Transmission by Aedes aegypti Mosquitoes in the Americas. J Infect Dis (2016) 1.30

Zika Virus Targets Human STAT2 to Inhibit Type I Interferon Signaling. Cell Host Microbe (2016) 1.25

Zika Virus Targets Different Primary Human Placental Cells, Suggesting Two Routes for Vertical Transmission. Cell Host Microbe (2016) 1.24

Potential for Zika virus introduction and transmission in resource-limited countries in Africa and the Asia-Pacific region: a modelling study. Lancet Infect Dis (2016) 1.20

Zika Virus: a Review from the Virus Basics to Proposed Management Strategies. Mediterr J Hematol Infect Dis (2016) 1.17

Western Zika Virus in Human Fetal Neural Progenitors Persists Long Term with Partial Cytopathic and Limited Immunogenic Effects. Cell Rep (2016) 1.16

Time Lags between Exanthematous Illness Attributed to Zika Virus, Guillain-Barré Syndrome, and Microcephaly, Salvador, Brazil. Emerg Infect Dis (2016) 1.13

Broadly Neutralizing Activity of Zika Virus-Immune Sera Identifies a Single Viral Serotype. Cell Rep (2016) 1.11

Estimated Zika virus importations to Europe by travellers from Brazil. Glob Health Action (2016) 1.08

Prevention and Control of Zika as a Mosquito-Borne and Sexually Transmitted Disease: A Mathematical Modeling Analysis. Sci Rep (2016) 1.07

Zika virus: An update on epidemiology, pathology, molecular biology, and animal model. J Med Virol (2016) 1.02

Vaccine Mediated Protection Against Zika Virus-Induced Congenital Disease. Cell (2017) 1.01

Association between Guillain-Barré syndrome and Zika virus infection. Lancet (2016) 1.01

Association between Guillain-Barré syndrome and Zika virus infection. Lancet (2016) 0.97

Instrument-Free Point-of-Care Molecular Detection of Zika Virus. Anal Chem (2016) 0.97

Assessment of Local Mosquito Species Incriminates Aedes aegypti as the Potential Vector of Zika Virus in Australia. PLoS Negl Trop Dis (2016) 0.95

Zika viral dynamics and shedding in rhesus and cynomolgus macaques. Nat Med (2016) 0.95

Coinfections of Zika and Chikungunya Viruses in Bahia, Brazil, Identified by Metagenomic Next-Generation Sequencing. J Clin Microbiol (2016) 0.95

Times to key events in Zika virus infection and implications for blood donation: a systematic review. Bull World Health Organ (2016) 0.95

Emerging Role of Zika Virus in Adverse Fetal and Neonatal Outcomes. Clin Microbiol Rev (2016) 0.94

Serodiagnosis of Zika virus (ZIKV) infections by a novel NS1-based ELISA devoid of cross-reactivity with dengue virus antibodies: a multicohort study of assay performance, 2015 to 2016. Euro Surveill (2016) 0.94

Zika virus and Guillain-Barré syndrome: another viral cause to add to the list. Lancet (2016) 0.93

The global spread of Zika virus: is public and media concern justified in regions currently unaffected? Infect Dis Poverty (2016) 0.93

Assessing Seasonal Risks for the Introduction and Mosquito-borne Spread of Zika Virus in Europe. EBioMedicine (2016) 0.92

Highly diversified Zika viruses imported to China, 2016. Protein Cell (2016) 0.91

Assay optimization for molecular detection of Zika virus. Bull World Health Organ (2016) 0.90

Detecting Guillain-Barré syndrome caused by Zika virus using systems developed for polio surveillance. Bull World Health Organ (2016) 0.90

Zika. An emerging teratogenic virus. Saudi Med J (2016) 0.90

How Did Zika Virus Emerge in the Pacific Islands and Latin America? MBio (2016) 0.90

The epidemiology and transmissibility of Zika virus in Girardot and San Andres island, Colombia, September 2015 to January 2016. Euro Surveill (2016) 0.90

Full Genome Sequence and sfRNA Interferon Antagonist Activity of Zika Virus from Recife, Brazil. PLoS Negl Trop Dis (2016) 0.90

Zika Virus: Immunity and Vaccine Development. Cell (2016) 0.89

Zika (PRVABC59) Infection Is Associated with T cell Infiltration and Neurodegeneration in CNS of Immunocompetent Neonatal C57Bl/6 Mice. PLoS Pathog (2016) 0.89

Zika Virus Seroprevalence, French Polynesia, 2014-2015. Emerg Infect Dis (2017) 0.89

Differential Responses of Human Fetal Brain Neural Stem Cells to Zika Virus Infection. Stem Cell Reports (2017) 0.87

Scoping Review of the Zika Virus Literature. PLoS One (2016) 0.87

Extended surface for membrane association in Zika virus NS1 structure. Nat Struct Mol Biol (2016) 0.87

Storm drains as larval development and adult resting sites for Aedes aegypti and Aedes albopictus in Salvador, Brazil. Parasit Vectors (2016) 0.86

Zika Virus and Chikungunya Virus CoInfections: A Series of Three Cases from a Single Center in Ecuador. Am J Trop Med Hyg (2016) 0.86

Dengue virus antibodies enhance Zika virus infection. Clin Transl Immunology (2016) 0.86

Unrecognized Emergence of Chikungunya Virus during a Zika Virus Outbreak in Salvador, Brazil. PLoS Negl Trop Dis (2017) 0.86

Guillain-Barré Syndrome After Zika Virus Infection in Brazil. Am J Trop Med Hyg (2016) 0.85

A Cost-Effectiveness Tool for Informing Policies on Zika Virus Control. PLoS Negl Trop Dis (2016) 0.85

Advances in Zika Virus Research: Stem Cell Models, Challenges, and Opportunities. Cell Stem Cell (2016) 0.84

Zika Fetal Neuropathogenesis: Etiology of a Viral Syndrome. PLoS Negl Trop Dis (2016) 0.84

Zika virus: An emergent neuropathological agent. Ann Neurol (2016) 0.84

Nonstructural Proteins Are Preferential Positive Selection Targets in Zika Virus and Related Flaviviruses. PLoS Negl Trop Dis (2016) 0.83

Modified mRNA Vaccines Protect against Zika Virus Infection. Cell (2017) 0.83

Contribution of intertwined loop to membrane association revealed by Zika virus full-length NS1 structure. EMBO J (2016) 0.82

The potential economic burden of Zika in the continental United States. PLoS Negl Trop Dis (2017) 0.82

Transmission of Zika virus through breast milk and other breastfeeding-related bodily-fluids: A systematic review. PLoS Negl Trop Dis (2017) 0.82

Potential for Zika Virus to Establish a Sylvatic Transmission Cycle in the Americas. PLoS Negl Trop Dis (2016) 0.81

Characterization of cytopathic factors through genome-wide analysis of the Zika viral proteins in fission yeast. Proc Natl Acad Sci U S A (2017) 0.81

Zika Virus Infection as a Cause of Congenital Brain Abnormalities and Guillain-Barré Syndrome: Systematic Review. PLoS Med (2017) 0.81

Comparative Analysis of Dengue and Zika Outbreaks Reveals Differences by Setting and Virus. PLoS Negl Trop Dis (2016) 0.81

The global threat of Zika virus to pregnancy: epidemiology, clinical perspectives, mechanisms, and impact. BMC Med (2016) 0.80

The Pathogenesis of the Demyelinating Form of Guillain-Barre Syndrome (GBS): Proteo-peptidomic and Immunological Profiling of Physiological Fluids. Mol Cell Proteomics (2016) 0.80

Zika Virus as an Emerging Global Pathogen: Neurological Complications of Zika Virus. JAMA Neurol (2016) 0.80

CNS infections: Zika virus infection could trigger Guillain-Barré syndrome. Nat Rev Neurol (2016) 0.80

Neuropathogenesis of Zika Virus in a Highly Susceptible Immunocompetent Mouse Model after Antibody Blockade of Type I Interferon. PLoS Negl Trop Dis (2017) 0.80

Competence of Aedes aegypti, Ae. albopictus, and Culex quinquefasciatus Mosquitoes as Zika Virus Vectors, China. Emerg Infect Dis (2017) 0.79

Prospects for a Zika Virus Vaccine. Immunity (2017) 0.79

Variation in Aedes aegypti Mosquito Competence for Zika Virus Transmission. Emerg Infect Dis (2017) 0.79

ZIKA-How fast does this virus mutate? Dongwuxue Yanjiu (2016) 0.79

Clinical and Epidemiological Characterization of Laboratory-Confirmed Autochthonous Cases of Zika Virus Disease in Mexico. PLoS Curr (2016) 0.79

Simple reverse genetics systems for Asian and African Zika viruses. Sci Rep (2016) 0.79

Persistent Zika Virus Detection in Semen in a Traveler Returning to the United Kingdom from Brazil, 2016. Emerg Infect Dis (2017) 0.79

The clinically approved antiviral drug sofosbuvir inhibits Zika virus replication. Sci Rep (2017) 0.79

Zika Virus Is Not Uniquely Stable at Physiological Temperatures Compared to Other Flaviviruses. MBio (2016) 0.79

Bioinformatic analysis reveals the expression of unique transcriptomic signatures in Zika virus infected human neural stem cells. Cell Biosci (2016) 0.79

A human antibody against Zika virus crosslinks the E protein to prevent infection. Nat Commun (2017) 0.79

Serologic Testing for Zika Virus: Comparison of Three Zika Virus IgM ELISAs and Initial Laboratory Experiences. J Clin Microbiol (2017) 0.79

A Reverse Genetics Platform That Spans the Zika Virus Family Tree. MBio (2017) 0.79

Biologic Evidence Required for Zika Disease Enhancement by Dengue Antibodies. Emerg Infect Dis (2017) 0.79

Animal Models of Zika Virus Infection, Pathogenesis, and Immunity. J Virol (2017) 0.79

Neurological manifestations of Zika virus infection. World J Virol (2016) 0.78

Development of a high-throughput colorimetric Zika virus infection assay. Med Microbiol Immunol (2017) 0.78

Structure in the variability of the basic reproductive number (R0) for Zika epidemics in the Pacific islands. Elife (2016) 0.78

Visual and Motor Deficits in Grown-up Mice with Congenital Zika Virus Infection. EBioMedicine (2017) 0.78

Zika virus and neurologic autoimmunity: the putative role of gangliosides. BMC Med (2016) 0.78

Neutralization mechanism of a highly potent antibody against Zika virus. Nat Commun (2016) 0.78

Identify-Isolate-Inform: A Tool for Initial Detection and Management of Zika Virus Patients in the Emergency Department. West J Emerg Med (2016) 0.78

Protective efficacy of Zika vaccine in AG129 mouse model. Sci Rep (2017) 0.78

Use of Blood Donor Screening Data to Estimate Zika Virus Incidence, Puerto Rico, April-August 2016. Emerg Infect Dis (2017) 0.78

Human Endometrial Stromal Cells Are Highly Permissive To Productive Infection by Zika Virus. Sci Rep (2017) 0.78

Humoral cross-reactivity between Zika and dengue viruses: implications for protection and pathology. Emerg Microbes Infect (2017) 0.77

Towards peptide vaccines against Zika virus: Immunoinformatics combined with molecular dynamics simulations to predict antigenic epitopes of Zika viral proteins. Sci Rep (2016) 0.77

Effects of Zika Virus Strain and Aedes Mosquito Species on Vector Competence. Emerg Infect Dis (2017) 0.77

ZIKV - CDB: A Collaborative Database to Guide Research Linking SncRNAs and ZIKA Virus Disease Symptoms. PLoS Negl Trop Dis (2016) 0.77

Articles cited by this

Zika virus outbreak on Yap Island, Federated States of Micronesia. N Engl J Med (2009) 17.89

Zika virus. I. Isolations and serological specificity. Trans R Soc Trop Med Hyg (1952) 13.73

Genetic and serologic properties of Zika virus associated with an epidemic, Yap State, Micronesia, 2007. Emerg Infect Dis (2008) 12.72

Zika virus, French polynesia, South pacific, 2013. Emerg Infect Dis (2014) 6.75

Guillain-Barré syndrome. N Engl J Med (2012) 6.28

First report of autochthonous transmission of Zika virus in Brazil. Mem Inst Oswaldo Cruz (2015) 6.24

Electrodiagnostic criteria for Guillain-Barrè syndrome: a critical revision and the need for an update. Clin Neurophysiol (2012) 6.08

Neurological manifestations of dengue infection. Lancet (2000) 5.69

Zika virus infection complicated by Guillain-Barre syndrome--case report, French Polynesia, December 2013. Euro Surveill (2014) 5.65

Molecular evolution of Zika virus during its emergence in the 20(th) century. PLoS Negl Trop Dis (2014) 4.37

Zika virus: following the path of dengue and chikungunya? Lancet (2015) 3.78

Detection of Zika virus in urine. Emerg Infect Dis (2015) 3.52

Zika virus: a report on three cases of human infection during an epidemic of jaundice in Nigeria. Trans R Soc Trop Med Hyg (1954) 3.19

Concurrent outbreaks of dengue, chikungunya and Zika virus infections - an unprecedented epidemic wave of mosquito-borne viruses in the Pacific 2012-2014. Euro Surveill (2014) 2.91

Detection of Zika virus in saliva. J Clin Virol (2015) 2.57

The epidemiology of Guillain-Barré syndrome worldwide. A systematic literature review. Neuroepidemiology (2008) 2.38

Outbreak of Exanthematous Illness Associated with Zika, Chikungunya, and Dengue Viruses, Salvador, Brazil. Emerg Infect Dis (2015) 2.33

Guillain-Barré syndrome after exposure to influenza virus. Lancet Infect Dis (2010) 2.32

Motor nerve terminal degeneration provides a potential mechanism for rapid recovery in acute motor axonal neuropathy after Campylobacter infection. Neurology (1997) 2.15

Guillain-Barré syndrome: pathogenesis, diagnosis, treatment and prognosis. Nat Rev Neurol (2014) 2.06

The Guillain-Barré syndrome: a true case of molecular mimicry. Trends Immunol (2004) 1.96

Diagnosis of Guillain-Barré syndrome and validation of Brighton criteria. Brain (2013) 1.93

Guillain-Barré syndrome and preceding infection with campylobacter, influenza and Epstein-Barr virus in the general practice research database. PLoS One (2007) 1.47

Zika virus spreads across Americas as concerns mount over birth defects. BMJ (2015) 1.40

Concern over Zika virus grips the world. Lancet (2016) 1.40

Neuromuscular manifestations of west nile virus infection. Front Neurol (2012) 1.34

Differences in patterns of progression in demyelinating and axonal Guillain-Barré syndromes. Neurology (2003) 1.32

Guillain-Barré syndrome after chikungunya infection. Emerg Infect Dis (2009) 1.24

Guillain-Barre syndrome, influenzalike illnesses, and influenza vaccination during seasons with and without circulating A/H1N1 viruses. Am J Epidemiol (2011) 1.21

Ganglioside antibodies and neuropathies. Curr Opin Neurol (2008) 1.15

Association of Japanese encephalitis virus infection with Guillain-Barré syndrome in endemic areas of south India. Acta Neurol Scand (1994) 1.13

Gangliosides as targets for autoimmune injury to the nervous system. J Neurochem (2007) 1.13

Differential distribution of HLA alleles in two forms of Guillain-Barré syndrome. J Infect Dis (1997) 1.09

Guillain-Barre syndrome: first description of a snake envenomation aetiology. J Neuroimmunol (2011) 1.01

Combinatorial glycoarray. Methods Mol Biol (2012) 1.01

A High-Performance Multiplex Immunoassay for Serodiagnosis of Flavivirus-Associated Neurological Diseases in Horses. Biomed Res Int (2015) 0.99

The demyelination neurophysiological criteria can be misleading in Campylobacter jejuni-related Guillain-Barré syndrome. Clin Neurophysiol (2013) 0.99